Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cell therapies
{{output}}
In currently ongoing adoptive T-cell therapies, T cells collected from patients are given back to them after ex vivo activation and expansion. In some cases, T cells are transduced with chimeric antigen receptor (CAR) or T-cell receptor (TCR) genes during the ... ...
